Clinical quality control guideline for coordinated thyroid disease management in Western China(2025 quality control nodes edition)(reprinted)
General Surgery Quality Control Center of Sichuan Province
Thyroid Surgery Innovation and Transformation Branch of Sichuan Medical Science and Technology Innovation Association
Li Zhihui
Cheng Ruochuan
Wang Ting
Zhang Kun
Abstract：In response to the"Healthy China 2030"strategy,the General Surgery Quality Control Center of Sichuan Province and the Thyroid Surgery Innovation and Transformation Branch of Sichuan Medical Science and Technology Innovation Association,jointly established 18 quality control(QC)nodes.This framework integrates evidence from many major domestic and international guidelines/consensus and regional clinical QC practices in Western China.The system encompasses three core dimensions:diagnostic logic accuracy(e.g.,TQC-01 for targeted screening to avoid over diagnosis by specifying high-risk ultrasonography indications);evidence-based treatment hierarchy(e.g.,TQC-06/TQC-08 standardizing staging protocols for surgical indications);treatment outcome optimization(e.g.,TQC-17 for longterm quality-of-life tracking).A four-phase closed-loop management structure is implemented.Screening intervention:imaging restricted to high-risk populations.Standardized diagnosis:initial nodule evaluation with serological testing(TQC-02)and pathological verification(TQC-04).Treatment protocolization:stratified execution of surgery/ablation indications(TQC-10).Dynamic prognosis monitoring:10-year survival tracking post-differentiated thyroid cancer surgery(TQC-17)and multidimensional ablation efficacy assessment(TQC-16).Under the collaborative governance of regional leading institutions,this framework has demonstrated significant impact:reduction of low-value care(e.g.,avoidance of non-indicated biopsy for suspicious lesion<1 cm),elimination of critical process omissions(including mandatory TNM staging compliance),and advancement toward regional healthcare quality homogenization.These contributions establish a replicable paradigm for enhancing China's national thyroid disease clinical quality ecosystem.
Keywords：Thyroid diseaseQuality controlDifferentiated thyroid carcinomaThyroid noduleAblation therapy
Publication Date：2025-08-20
Online Publishing Date：2026-01-30(First online date of this platform, not the publication date of the document)
Pages：23( 1-23 )